-+ 0.00%
-+ 0.00%
-+ 0.00%

Tempest Therapeutics names Nicholas Rossettos CFO, replacing Justin Trojanowski

PUBT·08/24/2026 20:44:02
Listen to the news
Tempest Therapeutics names Nicholas Rossettos CFO, replacing Justin Trojanowski
  • Tempest Therapeutics’ principal financial and accounting officer Justin Trojanowski will resign effective Sept. 1, 2026.
  • Nicholas Rossettos will take over as CFO, principal financial and accounting officer, treasurer, and corporate secretary effective Sept. 1.
  • Rossettos previously advised TransCode Therapeutics from April 2025, served as interim CFO of Sernova from March to October 2024.
  • He has provided CFO consulting services since 2012, including with Charles River CFO, following an earlier CFO role at Egenix from 2006 to 2012.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-363695), on August 24, 2026, and is solely responsible for the information contained therein.